Anti-LAG-3 antibody LBL-007 plus anti-PD-1 antibody toripalimab in advanced nasopharyngeal carcinoma and other solid tumors: an open-label, multicenter, phase Ib/II trial.
Saved in:
| Title: | Anti-LAG-3 antibody LBL-007 plus anti-PD-1 antibody toripalimab in advanced nasopharyngeal carcinoma and other solid tumors: an open-label, multicenter, phase Ib/II trial. |
|---|---|
| Authors: | Chen, Gang1,2 (AUTHOR), Sun, Dong-Chen1,2 (AUTHOR), Ba, Yi3 (AUTHOR), Zhang, Ya-Xiong1,2 (AUTHOR), Zhou, Ting1,2 (AUTHOR), Zhao, Yuan-Yuan1,2 (AUTHOR), Zhao, Hong-Yun2,4 (AUTHOR), Fang, Wen-Feng1,2 (AUTHOR), Huang, Yan1,2 (AUTHOR), Wang, Zhen5 (AUTHOR), Deng, Chao6 (AUTHOR), Hu, De-Sheng7 (AUTHOR), Wang, Wei8 (AUTHOR), Lin, Jin-Guan8 (AUTHOR), Li, Gui-Ling9 (AUTHOR), Luo, Su-Xia10 (AUTHOR), Fu, Zhi-Chao11 (AUTHOR), Zhu, Hai-Sheng12 (AUTHOR), Wang, Hui-Li13 (AUTHOR), Cai, Sheng-Li14 (AUTHOR) |
| Source: | Journal of Hematology & Oncology. 2/7/2025, Vol. 18 Issue 1, p1-10. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 17568722 |
|---|---|
| DOI: | 10.1186/s13045-025-01666-6 |
